Fenproporex

CHEMBL2105566 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
188.3 g/mol
LogP
1.9
Phase
4

A stimulant medication that acts on the central nervous system to suppress appetite, used as a short-term aid for weight loss. It is metabolically converted to amphetamine in the body, which contributes to its anorectic effects. Due to its potential for dependence and cardiovascular risks, its use is tightly restricted or banned in many countries.

分子量

188.2700 g/mol

LogP

1.90

TPSA

35.80 Ų

Lipinski 五规则

符合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(Cc1ccccc1)NCCC#N

InChI

InChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3

Molecular Formula

C12H16N2

HBD / HBA

1 / 2

可旋转键数

5

重原子数

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A stimulant medication that acts on the central nervous system to suppress appetite, used as a short-term aid for weight loss. It is metabolically converted to amphetamine in the body, which contributes to its anorectic effects. Due to its potential for dependence and cardiovascular risks, its use is tightly restricted or banned in many countries.

Yes, Fenproporex is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105566. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61810. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.